OR52H2P

Across TCGA pan-cancer cohorts, OR52H2P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR52H2P data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR52H2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR52H2P expression acts as an unfavorable survival marker, although some lineages such as OV and CESC show a favorable association.

UCS, COAD, and LIHC are the cancer types where OR52H2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	102	view →
LIHC	OS	Tertile	All	0.128	0.704	.011	27	view →
SKCM	DFS	Tertile	III,IV	0.210	0.516	.014	21	view →
OV	DFS	Tertile	III,IV	0.594	0.515	.028	18	view →
ACC	OS	Tertile	III,IV	0.189	0.757	<.001	18	view →
PRAD	OS	Tertile	All	0.976	0.996	.014	12	view →
BLCA	DFS	Tertile	III,IV	0.121	0.488	.020	9	view →
PCPG	DFS	Tertile	All	0.086	0.846	.001	9	view →
CESC	DFS	Tertile	All	0.908	0.514	.049	6	view →
THCA	DFS	Tertile	III,IV	1.000	0.677	.048	3	view →
LUSC	DFS	Tertile	II,III,IV	0.595	0.721	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR52H2P–UCS (DFS)

Open the UCS breakdown →